Biosupply Trends Marketplace News
Monday, December, 18, 2023

Study Finds Patients Treated with DMARDs Benefit from Fourth COVID-19 Vaccine

eBST Newsletter Main Article
 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 
Subscribe to the eBST Newsletter button
 

A new study suggests that the U.S. Centers for Disease Control and Prevention recommendation that patients receiving disease-modifying antirheumatic drugs (DMARDs) receive a fourth dose of the mRNA vaccine in addition to the three-dose primary series to protect against COVID-19 saves lives and reduces hospitalizations among patients in this high-risk group. read more ]

 
 

A New COVID-19 Variant, HV.1, Is Now Dominant

A new COVID-19 variant called HV.1 has become the dominant strain in the U.S. The highly infectious omicron subvariant has been circulating in the U.S. since the summer. During a two-week period ending on Nov. 11, HV.1 accounted for 29 percent of new COVID-19 infections in the U.S. read more ]

 

COVID-19 Illness Responsible for Most Hospitalizations and Deaths

A new report from the Centers for Disease Control and Prevention shows COVID-19 continues to fuel the most hospitalizations and deaths among all respiratory illnesses — about 15,000 hospitalizations and about 1,000 deaths every week. In addition, high levels of influenza-like illnesses are now being seen in up to 11 states. read more ]

Industry News

Industry News Image

From Vertex Pharmaceuticals

The U.S. Food and Drug Administration has approved Casgevy, the world's first medicine based on CRISPR gene-editing technology, to treat sickle cell disease, offering a potential cure for people born with this chronic and life-shortening blood disorder. read more ]

From Takeda Pharmaceuticals

Adzynma, the first genetically engineered protein product for preventative or on-demand enzyme replacement therapy for adult and pediatric patients with congenital thrombotic thrombocytopenic purpura, has been approved by the U.S. Food and Drug Administration. read more ]

From Eli Lily

The U.S. Food and Drug Administration has approved Eli Lilly's tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well. read more ]

From Octapharma USA

Octapharma USA's wilate, von Willebrand factor/coagulation factor VIII complex (human) lyophilized powder for solution for intravenous injection, has been given expanded approval by the U.S. Food and Drug Administration for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children aged 6 and older with any type of von Willebrand disease. read more ]

IVIG & Albumin Supply Index

IVIG and Albumin Days On Hand
     
 
 
 
     

What's New at FFF

COMIRNATY (PFIZER-BIONTECH)

COMIRNATY (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 single-dose glass prefilled syringes, single-dose plastic prefilled syringes and single-dose vials.

For more information about COMIRNATY, log in to biosupply.fffenterprises.com

OCTAGAM 10% (OCTAPHARMA USA)

OCTAGAM 10% is an immune globulin intravenous (human) liquid preparation indicated for the treatment of chronic immune thrombocytopenic purpura and dermatomyositis in adults. It is supplied in 2 g, 5 g, 10 g, 20 g or 30 g single-use bottles.

For more information about OCTAGAM 10%, log in to biosupply.fffenterprises.com

CARBOPLATIN (BPI LABS)

CARBOPLATIN injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents, and for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin. It is supplied in 5 mL fill in 10 mL, 15 mL fill in 20 mL, 45 mL fill in 50 mL and 60 mL fill in 100 mL multiple-dose vials.

For more information about CARBOPLATIN, log in to biosupply.fffenterprises.com

VECURONIUM BROMIDE (FRESENIUS KABI)

VECURONIUM BROMIDE for injection is indicated as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is supplied in 10 mL vials in units of 10.

For more information about VECURONIUM BROMIDE, log in to biosupply.fffenterprises.com

CISPLATIN (ACCORD HEALTHCARE)

CISPLATIN injection is a platinum-based drug indicated for the treatment of advanced testicular cancer, advanced ovarian cancer and advanced bladder cancer. It is supplied in 50 mg/50 mL (1 mg/mL) and 100 mg/100 mL (1 mg/mL) multiple-dose amber vials.

For more information about CISPLATIN, log in to biosupply.fffenterprises.com

YCANTH™ (VERRICA PHARMACEUTICALS)

YCANTH is indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older. It is supplied in a sealed glass ampule contained within a single-use applicator and enclosed in a protective paperboard sleeve. Each ampule contains 7 mg/mL of YCANTH.

For more information about YCANTH, log in to biosupply.fffenterprises.com

NOVAVAX COVID-19 VACCINE (NOVAVAX, INC)

The Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit) is a vaccine indicated for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in boxes of 10 doses of two 2.5mL-5 dose multi-dose vials.

For more information about NOVAVAX COVID-19 VACCINE (ADJUVANTED/PROTEIN SUBUNIT), log in to biosupply.fffenterprises.com

MODERNA COVID-19 VACCINE (mRNA) (MODERNA U.S. INC.)

Moderna COVID-19 Vaccine (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 5.5 mL multiple-dose vials and cartons of 10 7.5 mL multiple-dose vials.

For more information about MODERNA COVID-19 VACCINE (mRNA), log in to biosupply.fffenterprises.com

AREXVY (GLAXOSMITHKLINE)

AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied as two components: a single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles) in cartons of 10 vials.

For more information about AREXVY, log in to biosupply.fffenterprises.com

ABRYSVO (PFIZER INC.)

ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiration tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied in a kit that includes a vial of lyophilized antigen component, a prefilled syringe containing sterile water diluent component and a vial adapter in cartons of one, five and 10 kits.

For more information about ABRYSVO, log in to biosupply.fffenterprises.com

INDOCIN (ASSERTIO)

INDOCIN is a nonsteroidal anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis; moderate to severe osteoarthritis; acute painful shoulder (bursitis and/or tendinitis); and acute gouty arthritis. The 50 mg suppositories (indomethacin suppositories USP) are white, opaque and rectal supplied in boxes of 30.

For more information about INDOCIN, log in to biosupply.fffenterprises.com

MENVEO ONE-VIAL (GLAXOSMITHKLINE)

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in individuals 2 months through 55 years of age. It is supplied in cartons containing five vials of MenCYW-135 liquid conjugate component and cartons containing five vials of MenA lyophilized conjugate component.

For more information about MENVEO ONE-VIAL, log in to biosupply.fffenterprises.com

CALCIPOTRIENE FOAM (MAYNE PHARMA)

CALCIPOTRIENE FOAM is a vitamin D analog indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. It is supplied in a 60 gram aluminum can.

For more information about CALCIPOTRIENE FOAM, log in to biosupply.fffenterprises.com

DORYX MPC (MAYNE PHARMA)

DORYX MPC is a tetracycline-class drug indicated for the treatment of rickettsial infections; sexually transmitted infections; respiratory tract infections; specific bacterial infections; ophthalmic infections; anthrax, including inhalational anthrax (post-exposure); alternative treatment for selected infections when penicillin is contraindicated; adjunctive therapy in acute intestinal amebiasis and severe acne; and prophylaxis of malaria. The DORYX MPC (doxycycline hyclate delayed-release) 60 mg and 120 mg tablets are white, oval tablets containing yellow pellets and debossed with "D6" on one face and plain on the other. The 60 mg tablets are supplied in bottles of 60 and 120, and the 120 mg tablet is supplied in bottles of 30.

For more information about DORYX MPC, log in to biosupply.fffenterprises.com

LIDOCAINE HYDROCHLORIDE 4% (SINTETICA US LLC)

LIDOCAINE HYDROCHLORIDE injection 4% is indicated for the production of topical anesthesia of the mucous membranes of the respiratory tract or the genito-urinary tract. It may be injected trans-tracheally to anesthetize the larynx and trachea, and it may be administered by retrobulbar injection to provide anesthesia for ophthalmic surgery. It is supplied in a pack of 10 200 mg/5 mL single-dose ampules.

For more information about LIDOCAINE HYDROCHLORIDE 4%, log in to biosupply.fffenterprises.com

LIDOCAINE HYDROCHLORIDE 1%/2% (SINTETICA US LLC)

LIDOCAINE HYDROCHLORIDE injection 1% and 2% are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal, and by central neural techniques such as lumbar and caudal epidural blocks when the accepted procedures for these techniques as described in standard textbooks are observed. The 1% injection is supplied in a pack of 10 20 mg/2mL, 50 mg/5 mL and 100 mg/10 mL single-dose ampules. The 2% injection is supplied in 40 mg/2 mL, 100 mg/5 mL and 200 mg/10 mL single-dose ampules.

For more information about LIDOCAINE HYDROCHLORIDE 1%/2%, log in to biosupply.fffenterprises.com

HEPARIN SODIUM (TECHDOW)

HEPARIN SODIUM injection is an anticoagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism; prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism; and use as an anticoagulant in blood transfusions, extracorporeal circulation and dialysis procedures. It is supplied in a concentration of 1,000 mL in 2 mL single-dose vials and 1 mL, 10 mL and 30 mL multiple-dose vials; in a concentration of 5,000 mL in 1 mL and 10 mL multiple-dose vials; in a concentration of 10,000 mL in 1 mL and 5 mL multiple-dose vials; and in a concentration of 20,000 mL in 1 mL multiple-dose vials.

For more information about HEPARIN SODIUM, log in to biosupply.fffenterprises.com

MENQUADFI (SANOFI)

MENQUADFI meningococcal (groups A, C, Y, W) conjugate vaccine solution for intramuscular injection is indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y for use in individuals 2 years of age and older. It is supplied in a single-dose vial in packages of five vials.

For more information about MENQUADFI, log in to biosupply.fffenterprises.com

SODIUM BICARBONATE (EXELA PHARMA SCIENCES)

SODIUM BICARBONATE injection, USP, is indicated 1) in the treatment of metabolic acidosis that may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis, 2) in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products and 3) in severe diarrhea that is often accompanied by a significant loss of bicarbonate. It is supplied in 50 mL vials with either 20 or 25 vials per carton, and 10 mL vials with 25 vials per carton.

For more information about SODIUM BICARBONATE, log in to biosupply.fffenterprises.com

PRIORIX (GLAXOSMITHKLINE)

PRIORIX (vaccine, live) is indicated for active immunization for the prevention of measles, mumps and rubella in individuals 12 months of age and older. It is supplied in a box containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated syringes of sterile water diluent (packaged without needles). After reconstitution, each vial contains one dose (approximately 0.5 mL) of PRIORIX.

For more information about PRIORIX, log in to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprises' BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective October 1, 2023, through December. 31, 2023.

 
Calculate Your Current Medicare IVIG/SCIG Rates
Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
IVIG
ASCENIV J1554 $982.81 $967.05
BIVIGAM J1556 $145.92 $143.58
GAMMAGARD SD J1566 $153.13 $150.68
GAMMAPLEX J1557 $114.02 $112.19
OCTAGAM J1568 $89.57 $88.14
PANZYGA J1576 $131.41 $129.30
PRIVIGEN J1459 $95.18 $93.65
SCIG
CUTAQUIG J1551 $140.42 $138.17
CUVITRU J1555 $157.25 $154.73
HIZENTRA J1559 $127.28 $125.24
HYQVIA J1575 $168.88 $166.17
XEMBIFY J1558 $139.71 $137.47
IVIG / SCIG
GAMMAGARD LIQUID J1569 $88.92 $87.49
GAMMAKED J1561 $98.52 $96.94
GAMUNEX-C J1561 $98.52 $96.94
 

Resources

FFF customers may order the following complementary resources to help you with your practice:

Seasonal Flu Poster flu myths and facts brochure
immune globulin reference charts
•  Immune Globulin (Human) Chart
•  Hyperimmune Globulin Chart
•  Coagulation Catalog
•  Seasonal Influenza Vaccine Reference Guide
   

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to IG Living
IG Living Magazine cover
BioSupplyTrends Quarterly Magazine cover

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Subscribe to Biosupply Trends Quarterly Magazine
Home | About | Advertise | Subscribe | Contact – © FFF Enterprises, Inc.